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Abstract
Background: Malaria and schistosomiasis coinfection frequently occurs in tropical countries. This study evaluates the
influence of Schistosoma haematobium infection on specific antibody responses and cytokine production to recombinant
merozoite surface protein-1-19 (MSP1-19) and schizont extract of Plasmodium falciparum in malaria-infected children.
Methodology: Specific IgG1 to MSP1-19, as well as IgG1 and IgG3 to schizont extract were significantly increased in
coinfected children compared to P. falciparum mono-infected children. Stimulation with MSP1-19 lead to a specific
production of both interleukin-10 (IL-10) and interferon-c (IFN-c), whereas the stimulation with schizont extract produced
an IL-10 response only in the coinfected group.
Conclusions: Our study suggests that schistosomiasis coinfection favours anti-malarial protective antibody responses, which
could be associated with the regulation of IL-10 and IFN-c production and seems to be antigen-dependent. This study
demonstrates the importance of infectious status of the population in the evaluation of acquired immunity against malaria
and highlights the consequences of a multiple infection environment during clinical trials of anti-malaria vaccine candidates.
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Introduction
Plasmodium falciparum (Pf) malaria remains one of the major
public health issues in tropical countries and the vast majority of
childhood deaths due to malaria occur in sub-Saharan Africa [1].
Protective immunity to Pf malaria is slowly acquired after
several infections and is dependent on the intensity and duration of
the individual exposure to the parasite [2]. The P. falciparum
merozoite surface protein 1 (MSP1) and especially its highly
conserved C-terminal EGF-like module pair, known as MSP1-19 is
one of leading candidate antigens for a vaccine against the malaria
parasite blood stage [3,4]. In infected humans, humoral immune
responses to blood stage parasites play a primary role in providing
protection against malaria [5] and they are largely dependent on
cytophilic type immunoglobulin (Ig) antibodies (Abs) such as IgG1
and IgG3 isotypes [4]. In addition, a specific cellular immune
response and its associated cytokines, play a key protective or
pathological role during malaria. Some cytokines, such as
interferon-c (IFN-c) and Interleukin-10 (IL-10), are known to be
directly involved in the production of specific isotypes of anti-P.
falciparum Ab responses [6]. Hartgers et al. recently demonstrated
that in Ghanaian school children, there was an increase in specific
IL-10 production in helminth-infected individuals, compared to
non-helminth infected [7]. Therefore, the regulation of the specific
production of cytokines induced by such parasite infection could
have a substantial impact on the development of malaria
protection, as well as on its pathological consequences [7–8].
Intrinsic features of the immune system that develop with age
but also with the presence of other chronic infections may
influence malaria immunity [9–11]. Indeed, a chronic coinfection,
such as schistosomiasis, may have a key impact on the acquired
immune response to Plasmodium infection [9]. Previous studies,
relating the complexity of interactions between host response to
helminths and malaria infection, suggested possible consequences
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presence of Schistosoma coinfection during uncomplicated P.
falciparum malaria unbalances the regulation of the associated
inflammatory response [15]. Coinfection with helminthic parasites
could then constitute a confusing factor in the assessment of
efficacy of malaria-control intervention, including vaccine clinical
trials [7,12].
The present study evaluates the impact of coinfection by S.
haematobium (Sh) on the specific isotype Ab response and its
associated cytokine production to PfMSP1-19 and to schizont
extracts of P. falciparum asexual blood stage antigens (Ags) in
children living in a particular malaria endemic area, where
schistosomiasis appeared 15 years ago [15].
Materials and Methods
Subjects
The studied population was a cohort of 79 malaria infected
children living in the same area of the Senegal River basin (villages
of Lampsar, Taba Tache and Taba Dar Salam), as previously
described [16]. Two groups were identified in this cohort: children
infected by P. falciparum without a confirmed schistosomiasis (Pf)
(n=40; age mean=11 years; range: 7–15; villages of Taba Tache
and Taba Dar Salam) and malaria infected children presenting a
coinfection with S. haematobium (Pf-Sh) (n=39; age mean=10
years; range: 7–15; villages of Lampsar). Comparable mean age
and sex ratio were obtained. Absence of clinical morbidity for
malaria and schistosomiasis was a criterion of selection. The
detection of schistosomiasis infection was performed using the
referent parasite criteria (presence of eggs in urine or/and in feces).
Schistosoma infected patients presenting pathological cases of
schistosomiasis were treated but not included in the study. The
Taba Tache and Taba Dar Salam villages are located down-river
from Diama dam on the Senegal River where schistosomiasis is
absent as previously described (13–14) and as confirmed by the
present study.
Diagnosis
Pf infection. Pf infection was detected by Quantitative Buffy
Coat (QBC) (Becton Dickinson) and parasites were then counted
and identified on blood smears. These tests are commonly used in
malaria endemic areas and blood smears represent the referent
criterion to detect malaria infection [17]. Only red blood cells
infected by Pf were observed on positive slides. No other
Plasmodium species infection was detected. The studied
population was considered positive for malaria when Pf was
detected with the QBC test and confirmed by blood smear
observation, over a one-month period. In coinfected children, the
mean parasitaemia of P. falciparum was not significantly different
from the respective Pf mono-infected groups (Mann–Whitney U-
test). Mean of parasitaemia was 1617 per mm
3/blood for Pf
infected children versus 340 per mm3/blood for coinfected
children. During pre-selection, subjects showing high positivity
in QBC (+++ ) were excluded and immediately treated for
malaria. Children presenting clinical symptoms of mild or severe
malaria morbidity were not selected. The studied population did
not therefore present clinical symptoms of malaria morbidity.
None of the selected children had received anti-malaria treatment
in the month preceding the study.
Schistosoma heamatobium infection. The presence of Sh
eggs was evaluated in three samples of urine (urine filtration) using
microscopy. In the studied area and population, no Schistosoma
mansoni (Sm) infection was detected using Kato–Katz method.
In the villages of Taba Tache and Taba Dar Salam,
schistosomiasis infection has never been previously detected (16;
D. De Clercq, unpublished data). In addition to the complete
absence of schistosome eggs in faeces and urine, we have
confirmed the absence of Schistosoma infection in these villages by
evaluating the schistosome worm circulating anodic antigen (CAA)
in sera, as previously described [16].
In Lampsar village, the presence of Sm and Sh eggs was
evaluated in three samples of faeces (Kato–Katz method) or urine
(urine filtration), respectively. The intensity mean of urinary Sh
was 57 eggs/10 ml of urine.
None of the selected children had received anti-schistosome
treatment in the previous 6 months.
The study followed ethical principles and was approved by the
ethics committee of the Senegalese Ministry of Health. Written
informed consent was obtained from the study population by their
parents or guardians.
P. falciparum and schistosome antigens
The P. falciparum antigens were recombinant PfMSP1-19 and
schizont total antigens. PfMSP1-19 was produced in Pichia pastoris
as a hexa-His fusion [18]. PfMSP1-19 was provided by J.
McCormick and W. Morgan from National Institute for Medical
Research (London, UK). The schizont antigenic preparation of P.
falciparum is a soluble extract of schizont lysate obtained from
infected erythrocyte cultures [19].
Soluble Egg Antigen (SEA) is a total soluble extract of
schistosome eggs obtained from experimental infection in guinea
pigs by the Antigen Production Laboratory at the Pasteur Institute
of Lille, France.
Human Ab levels
Specific antibody levels to PfMSP1-19, schizont extract or SEA
in sera were determined by enzyme-linked immunosorbent assay
(ELISA).
PfMSP1-19 protein (0.5 mg/ml), schizont extract (0.5 mg/ml) or
SEA (5 mg/ml) were coated on 96-well plates (Nunc, Denmark) for
2 h 30 at 37uC. Plates were then blocked in PBS containing 0.5%
gelatin (Merck, Germany). The sera diluted in PBS/Tween were
incubated at 4uC overnight at a 1/100 dilution for IgG2, IgG3 and
IgG4, 1/50 for IgA and IgE, and at 1/1,000 for IgG1 detection to
schizont extract. For MSP1-19 antigen, a 1/100 dilution for IgG2,
IgG3, IgG4 and IgA, 1/50 for IgE and 1/1,500 for IgG1 were used
and for SEA, a 1/1,000 dilution for IgG1 and 1/100 for IgG3.
Corresponding biotinylated mAbs to human Ig isotypes (SBA, AL
or BD Pharmingen, CA, USA), were then incubated at a 1/1,000
dilution for IgG2, IgG4; 1/2,000 for IgG1, 1/750 for IgG3; 1/
1,500 for IgA and 1/250 for IgE (1 h 30 mn at 37uC). Streptavidin-
horseradish peroxidase-conjugated for IgG1,IgG2, IgG3,IgG4 and
IgA detection (1/1,500, 30 min at 37uC; Amersham, Les Ulis,
France) and ExtrAvidinR peroxidase conjugate for IgE detection
(1/5,000, 30 min at 37uC; Sigma, St-Louis, MO) were then added.
These ELISA conditions have been determined according to the
results of previous experiences. Colorimetric development was
allowed by means of ABTS (2,29-azino-bis (3-ethylbenzothiazoline
6-sulphonic acid) diammonium; Sigma) in 50 mM citrate buffer
(pH=4 containing 0.003% H2O2), and absorbance (OD) was
measured at 405 nm for IgG1, IgG2, IgG3, IgG4 and IgA. IgE
detection was revealed by OPD (1,2 - Phenylene Diamine
Dihydrochloride, Dako; Glostrup, Denmark). OPD was added for
30 minutes, followed by the addition of 2N H2SO4 to stop the
reaction and OD was measured at 492 nm. The same ELISA
procedures were performed in parallel for 30 sera from uninfected
European subjects used as negative controls. Individual results were
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to the formula: DOD = ODx-ODn, where ODx is the individual
OD value of infected patient and ODn was the arithmetic mean of
individual OD value for the 30 uninfected control individuals (ODn
value for IgE=0.107; IgG1=0.235; IgG2=0.123; IgG3=0.124;
IgG4=0.111, IgA=0.159 using schizont extract; IgE=0.09,
IgG1=0.156, IgG2=0.121, IgG3=0.128, IgG4=0.120, IgA=
0.181 using MSP1-19; IgG1=0.151, IgG3=0.147 using SEA).
Adsorption procedure of sera with schistosome antigens
Individual sera of Pf/Sh coinfected subjects were diluted with
PBS/Tween solution and incubated with schistosomes Soluble
Egg Antigens (SEA) at a final concentration of 200 mg/ml. The
mixture (sera-SEA) was incubated with gentle shaking for 5 h at
room temperature to allow the binding of specific Abs to SEA.
Specific IgG1 and IgG3 responses to SEA, to schizont extract of Pf
or to PfMSP1-19 were evaluated by ELISA (as described above)
before and after this adsorption procedure.
Whole blood culture and cytokine production
measurement
Sterile conditions were maintained during the whole blood
culture procedure, as originally described [20]. After white blood
cell count, blood samples were diluted in RPMI-1640 medium
(Gibco, France) supplemented with 2 mM L-glutamate, 8 mg/ml
Gentaline, and 1 mM Sodium Pyruvate in order to obtain 2610
6
mononuclear cells/ml. Blood cells were then distributed at the
rate of 1 ml/well in 24-well plates (Nunc). Antigens were added
to each culture well to a final concentration of 1 mg/ml for
MSP1-19 and 10 mg/ml for schizont extract. After 3 days of
incubation at 37uC in 5% CO2, the content of each culture well
was centrifuged, and supernatants were harvested and conserved
at 280uC. Supernatant concentrations of IL-10, IL-12, IL-13,
IFN-c and TGF-b were measured at day 3 by means of ELISA
kits according to the manufacturer’s instructions (Immunotech,
France). Specific cytokine production after Ag stimulation were
expressed as picograms, nanograms or International Units (IU)
per millilitre after the subtraction of the amount detected in
medium control cultures (non-stimulated conditions) for each
individual. Identical culture conditions were assessed with
mononuclear cells of 30 uninfected control individuals in which
no cytokine production was detected after Ag stimulation (data
not shown).
Statistical analysis
All data were analysed with Graph Pad Prism (Graph Pad
Software, CA, USA). After verifying that values did not assume a
Gaussian distribution, the nonparametric Mann-Whitney U-test
was used to compare values between both independent groups.
Correlation between specific Ab levels and the intensity of P.
falciparum infection was analysed using Spearman’s rank correla-
tion coefficient. All differences were considered significant at
p,0.05.
Results
Specific Ab responses to PfMSP1-19 and schizont extract
The comparison of specific isotype Ab response to MSP1-19
between children having been solely infected by P. falciparum (Pf)
and those coinfected with S. haematobium (Pf/Sh) was assessed
(Figure 1). IgG1 Ab levels were significantly higher in Pf/Sh-
infected children, compared to Pf-infected children (P,0.05)
(Figure 1A). The specific IgG3 response was detected in a few Pf/
Sh-infected children but no statistical difference was observed
between both groups (Figure 1A). No relevant anti-MSP1-19 IgG2,
IgG4 and IgA responses were observed in either group and the
levels of specific IgE Ab were similar between Pf- and Pf/Sh-
infected children (Figure 1A and 1B).
To evaluate the antigenic restriction of the observed isotype
variations according to infectious status, Ab responses against
whole schizont extract were also assessed. As observed with the
MSP1-19 A g ,s p e c i f i cI g G 2 ,I g G 4 ,I g A ,a n dI g Er e s p o n s e st o
total schizont extract were very low or similar between Pf and
Pf/Sh groups (Figure 2A and 2B). In contrast, specific IgG1 and
IgG3 Ab levels were significantly higher in Pf/Sh-infected
children compared to Pf-infected group (Figure 2A). These
results suggest that the observed difference in IgG1 responses is
not restricted to MSP1-19 antigen but is also found with P.
falciparum total extract.
Figure 1. Specific Ab responses to PfMSP1-19 in children
infected by P. falciparum (Pf - n=40) and coinfected with S.
haematobium (Pf-Sh - n=39) as determined by ELISA. Results
represent individual values of DOD and bars are the arithmetic mean for
each group. Statistical significance between each group is indicated. (A)
isotypes IgG1, IgG2, IgG3 and IgG4, (B) isotypes IgA and IgE.
doi:10.1371/journal.pone.0012764.g001
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IgG3 from coinfected patients with schistosome antigens
We cannot exclude that antigenic cross-reactions can at least
partly account for increased levels of anti-P. falciparum IgG1 and
IgG3 observed in Pf/Sh coinfected group. Adsorption experiments
with total schistosome antigens (SEA) of sera from coinfected
group were therefore performed in order to verify the possible
presence of IgG1 and IgG3 Abs cross-reacting with schistosome
and P. falciparum antigens.
First, results show a complete adsorption of anti-SEA IgG1 and
IgG3 Abs after incubation of the Pf/Sh patient sera with SEA,
indicating the efficiency of the experimental procedure (Table 1).
Using the same individual samples, we have evaluated the specific
IgG1 and IgG3 Ab levels against both P. falciparum Ags (schizont
extract and MSP1-19) before and after Abs adsorption. The
comparison shows that the mean OD values were similar between
SEA adsorbed and non adsorbed sera for both schizont extract
and MSP1-19 Ags (Table 1). These data show that increased levels
of IgG1 and IgG3 isotypes recognizing malaria antigens in the
coinfected group could not be explained by a cross reactivity to
Ags from both parasites.
Influence of intensity of P. falciparum infection on the
variation of anti-P. falciparum IgG1 and IgG3 levels
observed between groups of children
The correlation between specific Ab levels and the parasitaemia
due to P. falciparum infection was first analysed using Spearman’s
rank correlation coefficient, without taking into account the
coinfection status. This analysis did not reveal any significant
correlation (data not shown). This suggests that the observed
quantitative difference in the anti- P. falciparum Abs responses
between both groups were not due to differences in the intensity of
blood malaria parasites but could be related to the influence of
Schistosoma coinfection.
In addition, we have compared individual IgG1 and IgG3
responses against schizont Ags from both groups (coinfected vs.
mono-infected) matched on the level of Pf parasitaemia. We have
obtained 25 matched-pairs with parasitaemia values varying from
3 to 3780 infected erythrocytes per mm
3 of blood. The Wilcoxon t-
test was used to compare the means of the matched-pairs.
Regarding Ab responses against schizont Ags, the obtained value
was t=3.75 for IgG1 (p,0.01) and t=3.23 for IgG3 (p,0.001),
indicating that both groups were significantly different regarding
their IgG1 and IgG3 levels when patients were matched on their
parasitaemia.
Taken together these results indicate that the level of P.
falciparum parasitaemia should not be considered as a confounding
factor implicated in the observed variation of specific IgG1 and
IgG3 responses according to infectious status.
Production of cytokines in response to PfMSP1-19 and
schizont extract
The production of specific IFN-c, IL-10, IL-12, IL-13 and TGF-
b cytokines after in vitro stimulation of mononuclear cells from
studied individuals by schizont or MSP1-19, was evaluated in
children (Table 2). These cytokines have been selected according to
previous studies showing their role in the immune response
regulation during malaria infection and for some of them, their
role in the regulation of Ab isotype production [7]. The specific
production of IL-12, IL-13 and TGF-b to both P. falciparum antigens
was not significantly different between Pf and Pf/Sh groups. In
contrast, specific IL-10 and IFN-c production after MSP1-19 or
schizont extract stimulation, showed differences between both
groups. IL-10 production in presence of both Ags was significantly
higher in Pf/Sh-infected children than in Pf-infected children
(p=0.025, p=0.002, respectively). As for specific IFN-c secretion,
difference between both groups was only observed for the schizont
extract and was significantly higher in Pf/Sh-group compared to Pf-
group (p=0.02). Nevertheless, high IFN-c production to MSP1-19
was observed in few coinfected children (12/39) but the mean value
of IFN-c secretion in this group was not statistically higher than the
one observed in Pf-group (p=0.282). Background production of
IFN-c and IL-10 (medium alone) was similar between both groups
(IFN-c: 1.25 [mean] 62.38 [SEM] UI/ml in Pf group, and
4.95610.71 UI/ml in Pf/Sh group; NS) (IL-10: 248.16219 ng/ml
in Pf group, and 185.26140.3 ng/ml in Pf/Sh group; NS). These
last results indicate that the differences of cytokine production
according to infection status were observed only after the
stimulation by Plasmodium antigens.
Figure 2. Specific Ab responses to schizont extract in children
infected by P. falciparum (Pf - n=40) and coinfected with S.
haematobium (Pf-Sh - n=39) as determined by ELISA. Results
represent individual values of DOD and bars are the arithmetic mean for
each group. Statistical significance between each group is indicated. (A)
isotypes IgG1, IgG2, IgG3 and IgG4, (B) isotypes IgA and IgE.
doi:10.1371/journal.pone.0012764.g002
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Following the study of the influence of schistosomiasis
coinfection on the regulation of inflammatory factors in uncom-
plicated P. falciparum malaria [16], we have here evaluated the
influence of coinfection in children on the acquired specific
immune response to total Plasmodium Ags extract (schizont stage)
and to the specific PfMSP1-19 vaccine candidate. The greatest
interest of this study is that the selected children lived in the same
low malaria area (confirmed by the similar Pf parasitemia between
groups), without clinical manifestations, but living in villages from
the same studied area, where schistosomiasis was monitored since
several years (13–14). In particular, it indicated that Pf mono-
infected children have never been infected by Schistosoma.W e
demonstrated that S. haematobium coinfection influenced the
humoral immune response against malaria antigens by specifically
increasing IgG1 and IgG3 Abs levels. This increase was not
dependent on the age, on the intensity of malaria infection or on a
potential antigenic cross-reactivity. Indeed, the IgG1 and IgG3
responses to schizont extract were higher in Pf/Sh-infected
children compared to the Pf-infected group. However, only
specific IgG1 Ab response to the MSP1-19 antigen was significantly
increased in coinfected children suggesting that the influence of
coinfection could be antigen-dependent. During human malaria,
IgG1 and IgG3 are thought to play a key role in protection
[21,22]. It is believed that these cytophilic IgG subclasses can
neutralize parasites directly, by inhibiting parasite invasion or
growth in erythrocytes, or indirectly by a mechanism involving
cooperation between parasite–opsonising antibodies and mono-
cytes, through binding to the Tcc receptor IIA [23–25]. The
subclass response to MSP1-19 was biased towards IgG1 with a
minor component from the IgG3 subclass [26]. In addition, the
presence of specific IgG1 instead of IgG3 was associated with
clinical protection against malaria infection [27,28].
In the present study, we could also rule out the possible Abs
cross reactivity between total Sh and Pf antigens, by assessing SEA
adsorption experiments. In addition, statistical analysis showed the
absence of an effect of the intensity of P. falciparum parasitaemia on
these specific Ab responses to malaria antigens. Altogether, the
data suggest that chronic schistosome infection in malaria-infected
children could affect the specific immune response to P. falciparum.
In particular, S. haematobium coinfection appeared to influence the
specific isotype Ab responses involved in the development of
protective immunity to P. falciparum infection. Moreover, we and
others have described that P. falciparum coinfection also influenced
the anti-schistosome immune response in S. haematobium-infected
children [29,30]. In this case, anti-schistosome IgG3 level was
increased in coinfected individuals in contrast to the other IgG
subclasses. In regard to our present results, the co-occurrence of
schistosomiasis and malaria in individuals could have a particular
effect on the IgG3 isotype regulation. The specific IgG3 response
to MSP1-19 has been observed in 1/3 of coinfected children (12/
39) whereas this isotype response was not detected in children
infected only by Pf. Several immuno-epidemiological studies
indicate that the presence of anti-MSP1-19 IgG3 response could
be dependent to the studied site. For example, a very low IgG3
Table 1. Absence of cross reactivity of anti-P. falciparum IgG1 and IgG3 from coinfected patients with Schistosome antigens.
Schistosome Ag P. falciparum Ags
SEA SE PfMSP1-19
NA A N A A NA A
IgG1
a 1.02460.222 0.01960.09* 0.33660.063 0.32360.061 1.88560.319 1.76260.311
IgG3 0.41360.115 0.01360.004* 0.25960.065 0.34260.079 0.68360.257 0.70460.250
a: Results are mean 6 SEM of individual specific production (after subtracting the amount detected in unstimulated medium control cultures for each individual).
Ag: Antigen.
SEA: Schistosoma Egg Antigens.
SE: Schizont Extract.
A: Adsorbed Sera with SEA.
NA: Non Adsorbed Sera with SEA.
*: p,0.0009.
doi:10.1371/journal.pone.0012764.t001
Table 2. Specific cytokine production to PfMSP1-19 and Schizont extract in children infected by P. falciparum (Pf, n=40) or
coinfected by P. falciparum and S. haematobium (Pf-Sh, n=39).
PfMSP1-19 Schizont Extract
Pf Pf/Sh P value
b Pf Pf/Sh P value
b
IL-10
a (ng/ml) 14.7365.21 22.4264.89 0.025 36.64610.99 72.99610.79 0.002
IL-12 (pg/ml) 17.2465.63 16.8266.06 0.207 20.4767.47 26.2368.72 0.386
IL-13 (pg/ml) 2.3461.33 3.0761.09 0.219 4.2261.69 4.1062.08 0.495
IFN-c (pg/ml) 0.2660.11 4.2262.05 0.282 1.7260.48 11.1365.34 0.020
TGF-b (pg/ml) 6.7261.83 5.2361.89 0.286 12.6562.31 10.8161.60 0.259
a: Results are mean 6 SEM of individual specific production (after subtracting the amount detected in unstimulated medium control cultures for each individual).
b: P value between Pf and Pf/Sh groups (nonparametric Mann-Whitney U test). Differences are considered significant for P,0.05.
doi:10.1371/journal.pone.0012764.t002
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malaria endemic areas [26,28,31]. This difference might be due to
different genetic background of these populations and/or to a
different intensity of transmission in the studied areas or to
environmental factors. Indeed, it was speculated that the
differential evolution of plasma IgG1 and IgG3 antibodies resulted
from a different catabolism and/or use of these antibodies [32].
Thus, history of malaria exposure, seasonal transmission and the
short life of specific IgG3 to MSP1-19 antigen cannot be excluded
to explain the presence or the absence of this specific IgG3
response. Nevertheless, our results indicate that the presence of
specific IgG3 to MSP1-19 among some children living in an
endemic malaria area was observed when schistosomiasis
coinfection has been established. It could be of great interest to
confirm the observations of our study in other coinfection contexts.
Our study indicates that it will be crucial to systematically consider
the coinfection status of patients in studies concerning the anti-
malaria immunity. It strengthens the necessity to screen patients
for helminth infections and their immune influence before and
during malaria vaccine trials, as previously suggested [9].
We have demonstrated that the influence of S. haematobium
infection on specific immune response to Plasmodium Ags involves
specific cytokine production. Helminth infections seemed to
influence IL-12, IL-13 and TGF-b production under stimulation
with both malaria Ags. In contrast, specific IFN-c and IL-10
production to the schizont extract were significantly higher in the
coinfected group, which showed also a predominant anti-schizont
IgG1 and IgG3 Ab levels. In addition, specific IL-10 production to
MSP1-19 was significantly higher in the coinfected group
compared to children only infected by Pf, as observed for specific
IgG1 response. In vitro human studies prove that stimulation by
MSP1-19 preferentially elicits IL-10 production [33]. Moreover,
IL-10 production specific to schistosome antigens was very
relevant in children infected by schistosomes [34]. This cytokine
is known to favour the production of IgG1 and IgG3 isotypes,
especially during malaria infection [33,35]. In addition, specific
IgG3 response has been closely associated with the production of
IFN-c during human infectious diseases, such as Borrelia burgdorferi
[36] or S. haematobium chronic infections [F. Remoue, unpublished
data]. In the acute uncomplicated malaria, it has been
demonstrated that peripheral blood CD4+ T cells producing both
IFN-c and IL-10 were significantly increased during drug-induced
clearance of parasitaemia [37]. Moreover, it has been shown that
T cells from vaccinated healthy volunteers and adults naturally
exposed to malaria with MSP1-19 could produce both IFN-c and
IL-10 [38].
In our study, no statistical correlation of specific IFN-c or IL-10
productions with IgG1 and/or IgG3 production has been
observed. Nevertheless, we have shown an association between
the production of these cytokines and the regulation of these
specific isotypes according to the group of infection. With regard
to previous studies [33–37] and the present results, we can suggest
that IFN-c, acting in synergy with IL-10, could be associated to
events leading to the predominant IgG3 production as previously
observed during others parasitic infections [F. Remoue, unpub-
lished data]. In addition, it is likely that the production of anti-P.
falciparum IgG1 and IgG3 Abs could be differently regulated by IL-
10 and IL-10/IFN-c, respectively. This hypothesis is now under
investigation by analysing the in vitro isotype production after
cytokine stimulation of T cells from infected individuals.
The influence of environment, genetic background or nutri-
tional status cannot be ruled out to explain the variation of specific
immunity observed in our study. Nevertheless, the concomitant
infections such as schistosomiasis in children may influence the
acquired anti-malaria Ab response and associated cytokine
production. The presence of chronic schistosomiasis infection
could specifically increase IL-10 and IFN-c production in
coinfected children, a cytokine production which would positively
influence the production of cytophilic anti-malaria IgG1 and IgG3
isotypes, known to be protective during malaria infection.
Altogether, this study represents an approach of the regulation
of anti-malaria blood stage immunity by coinfection and indicates
that the helminthic infection status has to be taken into account in
the malaria epidemiological and vaccine studies.
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